New targets and new agents in HCC
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Raymond discusses new targets and agents for the treatment of hepatocellular carcinoma (HCC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
Tandem Talk 3: Hepatocellular carcinoma - Locoregional Treatment
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Chris Verslype arguest for the locoregional treatment of hepatocellular carcinoma (HCC).
Author: imedex
Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts
New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis
GRACE is happy to present the 9th and final video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett V...
Author: cancergrace
Added: 08/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 18, 2016 Category: Cancer & Oncology Source Type: podcasts
Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the introduction of new data of the new single-agent cabozantinib for advanced renal cell carcinoma. The agent is a dual MET and VEGFR2 inhibitor...
Author: VJOncology
Added: 08/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 18, 2016 Category: Cancer & Oncology Source Type: podcasts
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
Toni Choueiri, MD of the Dana-Farber Cancer Center, Boston, MA discusses the Phase III METEOR randomized clinical trial of cabozantinib vs everolimus in advanced clear cell renal cell carcinoma (ccRCC...
Author: VJOncology
Added: 08/17/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 17, 2016 Category: Cancer & Oncology Source Type: podcasts
Treating advanced/metastatic urothelial carcinoma: recent developments in the BGJ398 clinical trial
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the BGJ398 clinical trial in patients with previously treated advanced/metastatic urothelial carcinoma (NCT01004224). He explains that for the pa...
Author: VJOncology
Added: 08/17/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 17, 2016 Category: Cancer & Oncology Source Type: podcasts
Brian I. Rini, MD, FACP - Making Sense of the Expanding Treatment Landscape in Renal Cell Carcinoma: Implications for Clinical Decision Making
Making Sense of the Expanding Treatment Landscape in Renal Cell Carcinoma: Implications for Clinical Decision Making (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - July 29, 2016 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Laryngeal Squamous Cell Carcinoma Quality Metrics (JAMA Otolaryngology —Head & Neck Surgery)
Interview with Brian Nussenbaum, MD, author of Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 19, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Laryngeal Squamous Cell Carcinoma Quality Metrics
Interview with Brian Nussenbaum, MD, author of Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 19, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Atezolizumab as 1L therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma mUC: IMvigor210 cohort 1
Press brief by Arjun Vasant Balar, MD of the NYU Langone Medical Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Author: VJOncology
Added: 06/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 29, 2016 Category: Cancer & Oncology Source Type: podcasts
Atezolizumab differences in Squamous Cell Carcinomas versus the Non-Squamous Cancers #ASCO16
Dr. Fadi Braiteh, MD of Comprehensive Cancer Centers of Nevada describers the differences in Squamous Cell Carcinomas versus the Non-Squamous Cancers when using Atezolizumab
Author: ASCO2016
Added: 06/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 24, 2016 Category: Cancer & Oncology Source Type: podcasts
Anti PD-1 versus Anti PD-L1 in urothelial carcinoma
Petros Grivas, MD discusses anti PD-1 versus anti PD-L1 in urothelial carcinoma
Author: ASCO2016
Added: 06/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts
Atezolizumab is the first new drug approved for advanced urothelial carcinoma since mid 1990s
Dr Robert Dreicer, MD of University of Virginia Health System highlights the importance of the FDA approval of Atezolizumab at ASCO 2016
Author: ASCO2016
Added: 06/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2016 Category: Cancer & Oncology Source Type: podcasts
Best of the Day: ASCO 2016 - GU Malignancies
In this Best of the Day™ interview from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Anne S. Tsao and Bernard Escudier discuss the latest updates in renal cell carcinoma a...
Author: imedex
Added: 06/10/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2016 Category: Cancer & Oncology Source Type: podcasts
Lifestyle Associations With US Cancer Incidence and Mortality (JAMA Oncology)
Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 19, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
